1. Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapy. Issue 1 (1st January 2021) Authors: Waldhauer, Inja; Gonzalez-Nicolini, Valeria; Freimoser-Grundschober, Anne; Nayak, Tapan K; Fahrni, Linda; Hosse, Ralf J.; Gerrits, Danny; Geven, Edwin J. W.; Sam, Johannes; Lang, Sabine; Bommer, Esther; Steinhart, Virginie; Husar, Elisabeth; Colombetti, Sara; Van Puijenbroek, Erwin; Neubauer, Mar... Journal: MAbs Issue: Volume 13:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗